Vivaldi Coelho Rogerio, a director at Crinetics Pharmaceuticals ($CRNX), made two open market sales of company stock over the past year, totaling about $181 thousand. His most recent sale occurred on March 12, 2026. These transactions rank 8,642nd out of 11,678 insiders in our database by sale value, well below the average of $8.6 million across roughly 6.4 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Director | S | Common Stock | 4477 | $36.08 | 16,823.0000 | 94,548,000 | 21.02% | 0.00% |
| March 12, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Director | S | Common Stock | 523 | $36.77 | 16,300.0000 | 94,548,000 | 3.11% | 0.00% |
| March 6, 2026 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | M | Dividend Equivalent Units | 1174 | $0.00 | 0.0000 | 1,176,700,000 | 100.00% | 0.00% |
| March 6, 2026 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | M | Restricted Stock Units | 23660 | $0.00 | 0.0000 | 1,176,700,000 | 100.00% | 0.00% |
| March 6, 2026 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | M | Common Stock | 1175 | $0.00 | 46,526.0000 | 1,176,700,000 | 2.59% | 0.00% |
| March 6, 2026 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | A | Restricted Stock Units | 15890 | $0.00 | 15,890.0000 | 1,176,700,000 | 9999.99% | 0.00% |
| March 6, 2026 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | M | Common Stock | 23660 | $0.00 | 45,351.0000 | 1,176,700,000 | 109.08% | 0.00% |
| June 11, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 11, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Not found | A | Common Stock | 6900 | $0.00 | 21,300.0000 | 92,926,000 | 47.92% | 0.01% |
| March 6, 2025 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | A | Restricted Stock Units | 23660 | $0.00 | 23,660.0000 | 1,200,400,000 | 9999.99% | 0.00% |
| March 4, 2025 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | M | Dividend Equivalent Units | 423 | $0.00 | 0.0000 | 1,200,400,000 | 100.00% | 0.00% |
| March 4, 2025 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | M | Common Stock | 21267 | $0.00 | 21,267.0000 | 1,200,400,000 | 9999.99% | 0.00% |
| March 4, 2025 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | M | Common Stock | 424 | $0.00 | 21,691.0000 | 1,200,400,000 | 1.99% | 0.00% |
| March 4, 2025 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | M | Restricted Stock Units | 21267 | $0.00 | 0.0000 | 1,200,400,000 | 100.00% | 0.00% |
| June 7, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| June 7, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Not found | A | Common Stock | 3400 | $0.00 | 14,400.0000 | 68,175,000 | 30.91% | 0.00% |
| June 3, 2024 | Viatris Inc | $VTRS | Vivaldi Coelho Rogerio | Not found | A | Restricted Stock Units | 21267 | $0.00 | 21,267.0000 | 1,217,400,000 | 9999.99% | 0.00% |
| June 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Director | A | Common Stock | 6000 | $0.00 | 11,000.0000 | 0 | 120.00% | 0.00% |
| June 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Vivaldi Coelho Rogerio | Director | P | Common Stock | 5000 | $22.06 | 5,000.0000 | 0 | 9999.99% | 0.00% |